Cipla
Y.K. Hamied is the current Non-Executive Chairman at Cipla, a global pharmaceutical company. Prior to this, they worked at Goldman Sachs in their Investment Management Division as an Associate and Consultant Relations from July 2000 to May 2004.
Y. K. Hamied completed a M.Sc. in International Accounting and Finance from The London School of Economics and Political Science (LSE).
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Cipla
18 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.